Clinical laboratories are under increasing pressure to deliver higher throughput, faster turnaround times, and more consistent results. Across diagnostics, new platforms are emerging that aim to reduce manual workload, connect fragmented workflows, and introduce AI-assisted decision support across both operational and analytical domains.
AI moves deeper into pathology workflows
Digital pathology is one of the clearest examples of this shift. Proscia has introduced the fifth generation of its Concentriq platform, embedding domain-specific vision, language, and multimodal AI models directly into case review and biomarker discovery workflows. Rather than functioning solely as an image viewer, the system combines whole-slide images with clinical context, laboratory protocols, and translational data to support interpretation and analysis. The goal is to reduce time spent navigating complex cases while improving the structure and consistency of biomarker-related workflows in both diagnostic and research settings.
Agentic AI targets lab operations
Beyond interpretation, AI is also being applied to laboratory operations themselves. Tecan has integrated Agentic AI capabilities into its Introspect analytics platform using NVIDIA’s BioNeMo Agent Toolkit. Instead of simply monitoring performance, the system is designed to analyze workflow and operational data continuously and recommend actions before issues affect throughput or quality. Early access is now available in pharmaceutical, biotechnology, and clinical laboratory environments, reflecting growing interest in predictive rather than reactive lab management tools.
QC workflows shift toward centralized oversight
Quality control (QC) remains a persistent operational bottleneck in many clinical laboratories, particularly those managing multiple instruments or sites. Thermo Fisher Scientific’s LabLink 360 Quality Assurance Software consolidates QC data into a centralized dashboard and automates routine review steps. The system also introduces peer-group benchmarking and multi-site visibility, allowing laboratories to compare performance and identify out-of-control events more quickly. Designed to integrate with MAS quality control products and automation workflows, the platform is positioned to reduce manual reconciliation and shorten review-to-resolution cycles.
Sequencing workflows target upstream bottlenecks
In next-generation sequencing (NGS), attention is increasingly focused on reducing variability earlier in the workflow. Watchmaker Genomics has launched two tools aimed at improving library preparation and amplification accuracy. The EquiPlex Normalization Kit replaces traditional concentration and dilution steps with a Cas9-based binding approach to standardize library input, while the Equinox Prime amplification system is designed to reduce indel artifacts in repetitive genomic regions. Together, the technologies are intended to improve scalability and data consistency in high-throughput applications such as oncology, whole-genome, and exome sequencing.
Automation expands in transfusion medicine
Automation is also advancing in transfusion laboratories, where consistency and traceability are critical. Grifols has introduced Evanzys IH, a modular, fully automated immunohematology system designed to streamline blood typing and sample processing. The track-enabled platform reduces manual intervention while supporting end-to-end workflow management from sample handling through results reporting. The system extends the company’s existing immunohematology portfolio and reflects continued demand for more connected and scalable transfusion workflows.
Point-of-care molecular testing accelerates diagnosis
At the patient-facing end of the workflow, rapid molecular diagnostics continue to gain traction. DiaSorin has received FDA 510(k) clearance and a CLIA waiver for its LIAISON NES Group A Streptococcus assay, expanding its point-of-care molecular testing menu. The PCR-based test delivers results in approximately 15 minutes and is designed for use during a single patient visit, reducing reliance on follow-up culture or centralized testing. The system emphasizes simplified workflow design, with minimal hands-on time and room-temperature reagents, supporting faster clinical decision-making in outpatient settings.
Across these developments, it’s clear that laboratories are moving toward tighter integration of data, automation, and AI-assisted decision-making. Whether in pathology, sequencing, quality control, or point-of-care testing, the emphasis is increasingly on reducing manual steps, improving consistency, and enabling faster, more informed clinical decisions.
Note: This product news article was generated by AI based on a published press release, followed by a review from human editors.
